Inherited genetic markers discovered to date are able to identify a significant number of men at considerably elevated risk for prostate cancer
about
East meets West: ethnic differences in prostate cancer epidemiology between East Asians and CaucasiansThe role of single nucleotide polymorphisms in predicting prostate cancer risk and therapeutic decision makingEstimating the predictive ability of genetic risk models in simulated data based on published results from genome-wide association studies.Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial.A review of cancer risk prediction models with genetic variants.Prostate cancer in young men: an important clinical entity.Functional annotation of risk loci identified through genome-wide association studies for prostate cancer.Assessing interactions of two loci (rs4242382 and rs10486567) in familial prostate cancer: statistical evaluation of epistasis.A genome-wide survey over the ChIP-on-chip identified androgen receptor-binding genomic regions identifies a novel prostate cancer susceptibility locus at 12q13.13.Predictive performance of prostate cancer risk in Chinese men using 33 reported prostate cancer risk-associated SNPs.Resolving the variable genome and epigenome in human disease.Association between EHBP1 rs721048(A>G) polymorphism and prostate cancer susceptibility: a meta-analysis of 17 studies involving 150,678 subjectsCommon genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)An examination of clinical differences between carriers and non-carriers of chromosome 8q24 risk alleles in a New Zealand Caucasian population with prostate cancer.Genetic score is an objective and better measurement of inherited risk of prostate cancer than family history.Prostate cancer risk-associated genetic markers and their potential clinical utilityPopulation-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer.Utility of genome-wide association study findings: prostate cancer as a translational research paradigm.Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes.Current status of genome-wide association studies in cancer.New concepts concerning prostate cancer screening.Multigene panels in prostate cancer risk assessment: a systematic review.stageR: a general stage-wise method for controlling the gene-level false discovery rate in differential expression and differential transcript usage.Prediction of individual genetic risk to prostate cancer using a polygenic score.Genetic score of multiple risk-associated single nucleotide polymorphisms is a marker for genetic susceptibility to bladder cancer.Clinical uncertainty of prostate cancer genetic risk panels.Risk estimates for complex disorders: comparing personal genome testing and family history.
P2860
Q26827438-920C80EF-A104-47B6-9DE1-44780EE7C072Q27025062-00C6D7E0-F745-46A3-9A1F-802C1D5232F6Q30834328-E25CD929-4212-4616-BE04-A729D8CC308CQ33883502-FB818A06-6C6E-4CEA-964E-D1A80444B33CQ34265269-E765C71A-3D8B-4F07-BB72-F5EB20C44B2DQ34314644-A42F3CBF-0B98-4478-A584-E08BE957773DQ34757927-0B0479BC-6749-4BA5-819A-AE78AC19FAEDQ35107494-7DA5E671-2712-466C-99F8-BCADB65BFE1FQ35535768-C8DAD855-D210-4F49-A263-CCDF58EB86E4Q35597195-1199D65E-9285-4159-A9E4-1264466989A2Q35640065-3629388E-CF6C-47BF-864A-AF3BAFB6D016Q35846834-2358C626-B845-4597-A6CB-6F4DA471FF90Q35868793-59AB44AA-524D-44B8-B9B9-895B635C332CQ36663319-60667AC9-811A-4223-A050-62B838F2D1E5Q37062126-8D0695B2-3211-4F25-9DC0-E6A74836E763Q37085446-B0139079-646D-41BC-868E-175E2277BA02Q37113165-D91C6323-AB72-4A97-85BF-DFAA6A15E102Q37122541-8138F8BC-682D-46CC-81D4-39C00F4CB508Q37541989-A0C1E104-42BA-4E39-AF69-A1FD1F113400Q37890286-E31BE9D3-85AF-4554-AAF9-7B222CAA87ABQ38220183-C5313429-BA37-4691-8E2A-DB3C81EE5781Q38596777-0DEC6341-A8FC-41DB-AA2F-548D3CCA4A3FQ41292373-FFFBE00B-6A28-41A0-B5D7-7A804DB556CAQ41584352-E47D7403-E318-4292-B2A3-F17E3C2A087CQ44310648-70E945DF-637D-4A1F-8C95-3342C35689A2Q45920438-0F73AC92-0659-44FC-BA00-A8B2FBB5802EQ45968045-4CC053D6-0662-4C18-A17C-E1C6660089E4
P2860
Inherited genetic markers discovered to date are able to identify a significant number of men at considerably elevated risk for prostate cancer
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Inherited genetic markers disc ...... vated risk for prostate cancer
@ast
Inherited genetic markers disc ...... vated risk for prostate cancer
@en
Inherited genetic markers disc ...... vated risk for prostate cancer
@nl
type
label
Inherited genetic markers disc ...... vated risk for prostate cancer
@ast
Inherited genetic markers disc ...... vated risk for prostate cancer
@en
Inherited genetic markers disc ...... vated risk for prostate cancer
@nl
prefLabel
Inherited genetic markers disc ...... vated risk for prostate cancer
@ast
Inherited genetic markers disc ...... vated risk for prostate cancer
@en
Inherited genetic markers disc ...... vated risk for prostate cancer
@nl
P2093
P2860
P50
P356
P1433
P1476
Inherited genetic markers disc ...... vated risk for prostate cancer
@en
P2093
A Karim Kader
Aubrey R Turner
Fang-Chi Hsu
Fredrik Wiklund
Jielin Sun
S Lilly Zheng
William B Isaacs
Zheng Zhang
P2860
P304
P356
10.1002/PROS.21256
P577
2010-09-28T00:00:00Z